We previously applied this platform in developing a single-dose, intramuscular COVID-19 vaccine; the data showed that one dose of S protein with PELC works comparably to repeated doses of S protein alone for both B-cell and T-cell immunity [15]. Here, PROS1 is linked to COVID-19.